ABBV Total Assets
Everything the company owns at each quarter end — the balance-sheet total, not a flow.
Total Assets
Latest: $135.12B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $149.62B |
| 2020Q4 | $150.56B |
| 2021Q1 | $150.50B |
| 2021Q2 | $147.97B |
| 2021Q3 | $148.86B |
| 2021Q4 | $146.53B |
| 2022Q1 | $143.21B |
| 2022Q2 | $143.19B |
| 2022Q3 | $141.32B |
| 2022Q4 | $138.81B |
| 2023Q1 | $134.54B |
| 2023Q2 | $135.37B |
| 2023Q3 | $136.22B |
| 2023Q4 | $134.71B |
| 2024Q1 | $148.87B |
| 2024Q2 | $141.94B |
| 2024Q3 | $143.42B |
| 2024Q4 | $135.16B |
| 2025Q1 | $136.16B |
| 2025Q2 | $137.18B |
| 2025Q3 | $133.90B |
| 2025Q4 | $133.96B |
| 2026Q1 | $136.46B |
| 2026Q2 | $135.12B |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Total Assets
Total Assets
Total Assets
Latest Total Assets: $135.12B (2026Q2); -1.5% YoY; +12.9% CAGR since 2013Q1 (13.25y).
Across the 54 quarters from 2013Q1 to 2026Q2, Total Assets ranged from $26.70B in 2015Q1 to $150.56B in 2020Q4.
Chart and table show the latest 24 of 54 quarters.